07/18/2025
7:01 AM | CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
Citius Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/16/2025
8:21 PM | CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
Citius Oncology (Filer)
| Form 424B4 | |
07/16/2025
11:15 PM | CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
Citius Oncology (Filer)
| Form EFFECT | |
07/14/2025
4:22 PM | CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
Citius Oncology (Filer)
| Form S-1/A | |
07/14/2025
7:31 AM | CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
Citius Oncology (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
02/14/2025
3:45 PM | CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
Citius Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2025
3:30 PM | CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
Citius Oncology (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
02/06/2025
8:22 AM | CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
Citius Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/27/2025
3:30 PM | CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
Citius Oncology (Filer)
| Form 10-K/A | |
01/07/2025
8:10 AM | CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
Citius Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/06/2025
7:30 AM | CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
Citius Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for CTOR and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Citius Oncology and its competitors with MarketBeat's FREE daily newsletter. |
12/27/2024
4:10 PM | CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
Citius Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/27/2024
4:00 PM | CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
Citius Oncology (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
12/16/2024
4:05 PM | CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Mayersohn Joel David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
3:05 PM | CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Mazur Leonard L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
3:06 PM | Bartushak Jaime (Reporting)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
3:06 PM | CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
MCGRATH DENNIS M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
3:07 PM | CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Dutia Suren G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
3:07 PM | CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Webb Carol (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
3:08 PM | CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Smith Robert Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
3:09 PM | CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
HOLUBIAK MYRON Z (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
3:09 PM | CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Holuka Eugene Myron (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2024
4:08 PM | CITIUS ONCOLOGY, INC. (Subject)
CITIUS ONCOLOGY, INC. (Subject)
CITIUS ONCOLOGY, INC. (Subject)
Citius Oncology (Subject)
Hudson Bay Capital Management LP (Filed by)
| Form SC 13G/A | |
09/13/2024
7:30 AM | CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
Citius Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/05/2024
3:15 PM | CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
Citius Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/05/2024
8:23 AM | CITIUS ONCOLOGY, INC. (Subject)
CITIUS ONCOLOGY, INC. (Subject)
CITIUS ONCOLOGY, INC. (Subject)
Citius Oncology (Subject)
WOLVERINE ASSET MANAGEMENT LLC (Filed by)
| Form SC 13G/A | |
08/30/2024
3:05 PM | CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
HOLUBIAK MYRON Z (Reporting)
| Form 4/A | |
08/16/2024
4:25 PM | CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
Citius Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/16/2024
3:34 PM | CITIUS ONCOLOGY, INC. (Subject)
CITIUS ONCOLOGY, INC. (Subject)
CITIUS ONCOLOGY, INC. (Subject)
Citius Oncology (Subject)
Citius Pharmaceuticals, Inc. (Filed by)
| Form SC 13D | |
08/15/2024
11:53 AM | 10XYZ Holdings LP (Filed by)
CITIUS ONCOLOGY, INC. (Subject)
CITIUS ONCOLOGY, INC. (Subject)
CITIUS ONCOLOGY, INC. (Subject)
Citius Oncology (Subject)
| Form SC 13D/A | |
08/14/2024
5:19 PM | CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Webb Carol (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/14/2024
5:19 PM | CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Citius Pharmaceuticals, Inc. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/14/2024
5:20 PM | CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
MCGRATH DENNIS M (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/14/2024
5:20 PM | Bartushak Jaime (Reporting)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/14/2024
5:21 PM | CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Mazur Leonard L (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/14/2024
5:22 PM | CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Czuczman Myron (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/14/2024
5:23 PM | CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
HOLUBIAK MYRON Z (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/14/2024
5:23 PM | CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Smith Robert Joseph (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/14/2024
5:24 PM | CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Dutia Suren G (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/14/2024
5:24 PM | CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Webb Carol (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
5:25 PM | CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Citius Pharmaceuticals, Inc. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
HIDDEN IN THE BOOK OF GENESIS… (Ad) “This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 trillion vault of untapped American wealth.
Former CIA advisor Jim Rickards calls it the “Old Testament Wealth Code” — and says it could transform your financial future. He’s revealing everything in a new presentation. Watch Jim Rickards reveal the Old Testament Wealth Code |
08/14/2024
5:26 PM | CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
MCGRATH DENNIS M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
5:26 PM | Bartushak Jaime (Reporting)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
5:27 PM | CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Mazur Leonard L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
5:28 PM | CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Czuczman Myron (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
5:28 PM | CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
HOLUBIAK MYRON Z (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
5:29 PM | CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Dutia Suren G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2024
3:33 PM | CITIUS ONCOLOGY, INC. (Subject)
CITIUS ONCOLOGY, INC. (Subject)
CITIUS ONCOLOGY, INC. (Subject)
Citius Oncology (Subject)
Nasdaq Stock Market LLC (Filed by)
| Form 25-NSE | |
08/09/2024
3:22 PM | CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
Citius Oncology (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
